Skip to main content
Clemens Scherzer, MD, Neurology, Boston, MA

Clemens Rudolf Scherzer MD

Movement Disorder


Professor of Neurology, Harvard Medical School | Director, BWH Precision Neurology Program | Center Director, APDA Center for Advanced Parkinson Disease Research | Co-Founder and Co-Director, Harvard Biomarkers Study

Join to View Full Profile
  • Brigham and Women's Hospital, Harvard Medical School60 Fenwood RoadBoston, MA 02115

Dr. Scherzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Solve Parkinson's disease with precision neurology

    www.scherzerlaboratory.org

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Neurology, 1998 - 2001
  • Emory University School of Medicine
    Emory University School of MedicineInternship, Transitional Year, 1997 - 1998
  • University of Vienna Faculty of Medicine
    University of Vienna Faculty of MedicineClass of 1995

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2024 - 2026
  • MA State Medical License
    MA State Medical License 2003 - 2024
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease  
    Zheng, B. Liao, Z. Locascio, J. J. Lesniak, K. A. Roderick, S. S. Watt, M. L. Eklund, A. C. Zhang-James, Y. Kim, P. D. Hauser, M. A. Grunblatt, E. Moran, L. B. Mandel,..., Science Translational Medicine, 2010

Press Mentions

  • Precision Medicine for Parkinson’s: New Yale Center for Advanced Research
    Precision Medicine for Parkinson’s: New Yale Center for Advanced ResearchOctober 14th, 2024
  • Parkinson's Disease Could Have 3 Subtypes, Researchers Find
    Parkinson's Disease Could Have 3 Subtypes, Researchers FindJuly 23rd, 2024
  • Study Uncovers Genetic Variants Linked to Disease Progression
    Study Uncovers Genetic Variants Linked to Disease ProgressionMay 10th, 2021
  • Join now to see all

Grant Support

  • Genome-Wide Prediction of Dementia in Parkinson's DiseaseYALE UNIVERSITY2019–2025
  • Risk Marker For Parkinson'S Disease: Enabling Novel TherapiesNational Institute Of Neurological Disorders And Stroke2008–2011
  • Genomic Markers Of Disease Progression In Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke2008
  • Multigene Marker Of Progression In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2008
  • Genomic And Genetic Analysis Of Parkinson'S DiseaseNational Institute On Aging2004–2008

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: